We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current OVATF market cap is 556.87k. The company's latest EPS is CAD -0.0231 and P/E is -0.87.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 302k | 750k | 225k | 138k | 62k |
| Operating Income | -334k | -440k | -1.91M | -247k | -707k |
| Net Income | -835k | -1.18M | -2.39M | -794k | -813k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 1.84M | 3.25M | 769k | 105k | 77k |
| Total Liabilities | 362k | 143k | 63k | 188k | 729k |
| Total Equity | 1.48M | 3.11M | 706k | -83k | -652k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -952k | -1.39M | -886k | -670k | -336k |
| Investing | 895k | -685k | 1.16M | N/A | N/A |
| Financing | -29k | 2.05M | N/A | 47k | 356k |
| Market Cap | 556.87k |
| Price to Earnings Ratio | -0.87 |
| Price to Sales Ratio | 11.11 |
| Price to Cash Ratio | 14.29 |
| Price to Book Ratio | -1.08 |
| Dividend Yield | - |
| Shares Outstanding | 35.24M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 12.52k |
| 52 Week Change | -57.35% |
| 52 Week High | 0.04375 |
| 52 Week Low | 0.0101 |
| Spread (Intraday) | 0.28 (96.52%) |
| Company Name | Ovation Science Inc (PK) |
| Address |
1003 – 1166 alberni stree vancouver, british columbia V6E 3Z3 |
| Website | https://www.ovationscience.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
